# CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

> **NCT06847269** · PHASE2 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Refractory Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna
- **BIOLOGICAL:** CD19-CAR T cell Infusion

## Key facts

- **NCT ID:** NCT06847269
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2030-03
- **Final completion:** 2031-04
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06847269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06847269, "CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06847269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*